痴呆前心理行为障碍预测阿尔茨海默病的研究进展

doi:10.3969/j.issn.1003-9198.2024.05.019

[1] COLLABORATORS G D F. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 [J]. Lancet Public Health, 2022, 7(2): e105-e125.
[2] SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al. Alzheimer’s disease [J]. Lancet, 2021, 397(10284): 1577-1590.
[3] LIN Y, SHAN P Y, JIANG W J, et al. Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease [J]. Neurol Sci, 2019, 40(1): 41-49.
[4] SANFORD A M. Mild cognitive impairment [J]. Clin Geriatr Med, 2017, 33(3): 325-337.
[5] KOHLER S, ALLARDYCE J, VERHEY F R, et al. Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study [J]. Am J Geriatr Psychiatry, 2013, 21(2): 119-128.
[6] 刘翔,房圆,李霞.痴呆前心理行为障碍的临床表现及机制研究进展[J].上海交通大学学报(医学版),2020,40(2):263-266.
[7] ISMAIL Z, SMITH E E, GEDA Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment [J]. Alzheimers Dement, 2016, 12(2): 195-202.
[8] ISMAIL Z, MCGIRR A, GILL S, et al. Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline [J]. J Alzheimers Dis, 2021, 80(1): 459-469.
[9] ISMAIL Z, AGUERA-ORTIZ L, BRODATY H, et al. The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations [J]. J Alzheimers Dis, 2017, 56(3): 929-938.
[10] MALLO S C, ISMAIL Z, PEREIRO A X, et al. Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment [J]. J Alzheimers Dis, 2018, 66(1): 83-95.
[11] MALLO S C, ISMAIL Z, PEREIRO A X, et al. Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline [J]. Int Psychogeriatr, 2019, 31(2): 231-239.
[12] CUI Y, DAI S, MIAO Z, et al. Reliability and validity of the Chinese version of the mild behavioral impairment checklist for screening for Alzheimer’s disease [J]. J Alzheimers Dis, 2019, 70(3): 747-756.
[13] SOO S A, NG K P, WONG F, et al. Mild behaviour impairment checklist (MBI-C): is there a difference in ratings between patient and close informant? [J]. Alzheimer’s & Dementia, 2020, 16(S6): e039239.
[14] TARAGANO F E, ALLEGRI R F, HEISECKE S L, et al. Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group [J]. J Alzheimers Dis, 2018, 62(1): 227-238.
[15] MALLO S C, PEREIRO A X, CAMPOS-MAGDALENO M, et al. Neuropsychiatric symptoms in subjective cognitive complaints (SCC) and mild cognitive impairment (MCI): detecting changes over time with the mild behavioral impairment checklist (MBI-C) [J]. Alzheimer’s Dement, 2020, 16(Suppl 6):e041963.
[16] MCGIRR A, NATHAN S, GHAHREMANI M, et al. Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms [J]. Neurology, 2022, 98(21): e2132-e2139.
[17] DIETLIN S, SOTO M, KIYASOVA V, et al. Neuropsychiatric symptoms and risk of progression to Alzheimer’s disease among mild cognitive impairment subjects [J]. J Alzheimers Dis, 2019, 70(1): 25-34.
[18] RUTHIRAKUHAN M, ISMAIL Z, HERRMANN N, et al. Mild behavioral impairment is associated with progression to Alzheimer’s disease: a clinicopathological study [J]. Alzheimers Dement, 2022, 18(11): 2199-2208.
[19] EBRAHIM I M, GHAHREMANI M, CAMICIOLI R, et al. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: a longitudinal study of dementia-free older adults [J]. J Affect Disord, 2023, 332: 9-18.
[20] ACOSTA I, BORGES G, AGUIRRE-HERNANDEZ R, et al. Neuropsychiatric symptoms as risk factors of dementia in a Mexican population: a 10/66 dementia research group study [J]. Alzheimers Dement, 2018, 14(3): 271-279.
[21] JACK C R Jr, BENNETT D A, BLENNOW K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease [J]. Alzheimers Dement, 2018, 14(4): 535-562.
[22] JOHANSSON M, STOMRUD E, INSEL P S, et al. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease [J]. Transl Psychiatry, 2021, 11(1): 76.
[23] KARIKARI T K, PASCOAL T A, ASHTON N J, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts [J]. Lancet Neurol, 2020, 19(5): 422-433.
[24] GHAHREMANI M, WANG M, CHEN H Y, et al. Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal alzheimer disease [J]. Neurology, 2023, 100(7): e683-e693.
[25] LI Y, SCHINDLER S E, BOLLINGER J G, et al. Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques [J]. Neurology, 2022, 98(7): e688-e699.
[26] MIAO R, CHEN H Y, GILL S, et al. Plasma beta-amyloid in mild behavioural impairment - neuropsychiatric symptoms on the Alzheimer’s continuum [J]. J Geriatr Psychiatry Neurol, 2022, 35(3): 434-441.
[27] NAUDE J P, GILL S, HU S, et al. Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment [J]. J Alzheimers Dis, 2020, 76(3): 1017-1027.
[28] MATUSKOVA V, ISMAIL Z, NIKOLAI T, et al. Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort [J]. Front Aging Neurosci, 2021, 13: 643271.
[29] IMAI A, MATSUOKA T, NARUMOTO J. Emotional dysregulation in mild behavioral impairment is associated with reduced cortical thickness in the right supramarginal gyrus [J]. J Alzheimers Dis, 2023, 93(2): 521-532.
[30] YOON E J, LEE J Y, KWAK S, et al. Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment [J]. Front Aging Neurosci, 2022, 14: 1051621.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Metrics

Recommended 10

[1]	SUN Li, YIN Weihong, JING Jun, QIAN Xiali. Effects of intraoperative subanesthetic dose of esketamine on early postoperative cognitive dysfunction in elderly patients undergoing spinal surgery [J]. Practical Geriatrics, 2024, 38(10): 1039-1043.
[2]	YE Niansi, HU Hui, DENG Bei, LIU Xueting, ZHOU Shi, LI Yucan, WANG Xiaomeng. Current situation and influencing factors of oral health-related quality of life in elderly with mild cognitive impairment [J]. Practical Geriatrics, 2024, 38(7): 674-678.
[3]	. [J]. Practical Geriatrics, 2024, 38(5): 433-437.
[4]	. [J]. Practical Geriatrics, 2024, 38(5): 438-437.
[5]	. [J]. Practical Geriatrics, 2024, 38(5): 447-437.
[6]	GUO Jinhua, SHEN Tiemei, CHEN Ling, CUI Hong, WANG Xiaoxia, HUANG Qiao, HUANG Fang, LI Yun, YANG Manqing. Prevalence and risk factors of cognitive function in elderly inrural areas of Guangdong Province [J]. Practical Geriatrics, 2024, 38(5): 456-437.
[7]	WEI qian, CAI Yingyuan, WANG Shan,TAN Fuyun, LU Xiaowei. Relationship between serum thyrotropin and risk of cognitive impairment in elderly with normalthyroid function and subclinical hypothyroidism [J]. Practical Geriatrics, 2024, 38(5): 486-437.
[8]	JIAO Linna, LI Baoyi, WANG Qin, HE Jianli. Correlation of white matter lesions and cerebral cortex thickness with cognitive dysfunction after mild stroke in the elderly [J]. Practical Geriatrics, 2024, 38(3): 287-290.
[9]	GAO Na, XU Mengru, ZHANG Li, LIU Yuwen, WEI Xing. Construction and validation of a risk prediction model for motoric cognitive risk syndrome in the elderly in rural areas [J]. Practical Geriatrics, 2024, 38(4): 353-357.
[10]	. [J]. Practical Geriatrics, 2024, 38(4): 399-404.
[11]	. [J]. Practical Geriatrics, 2024, 38(4): 414-417.
[12]	LIU Yadong, GAO Langli, LYU Juan, GE Ning, YUE Jirong. Establishment of a new delirium screening scale for elderly inpatients in China [J]. Practical Geriatrics, 2024, 38(1): 28-33.
[13]	ZHANG Jia, LIU Xinwei, LIAN Hongyu, LIU Kexin, LI Zitao. Association of hemoglobin concentration with postoperative delirium after hip replacement in elderly patients [J]. Practical Geriatrics, 2024, 38(1): 64-67.